Cardlytics, Inc. (NASDAQ:CDLX) Receives Consensus Rating of "Hold" from Brokerages

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven brokerages that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $6.42.

CDLX has been the subject of several recent analyst reports. Needham & Company LLC restated a "hold" rating on shares of Cardlytics in a research report on Thursday, March 13th. Evercore ISI dropped their target price on shares of Cardlytics from $4.00 to $3.00 and set an "in-line" rating for the company in a report on Thursday, March 13th. Finally, Lake Street Capital decreased their price target on shares of Cardlytics from $5.00 to $3.00 and set a "hold" rating on the stock in a report on Thursday, March 13th.

Insider Buying and Selling at Cardlytics

In related news, CFO Alexis Desieno sold 8,854 shares of the stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total value of $32,494.18. Following the completion of the sale, the chief financial officer now directly owns 121,976 shares in the company, valued at $447,651.92. This represents a 6.77 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $3.92, for a total value of $59,427.20. Following the transaction, the chief executive officer now directly owns 215,494 shares in the company, valued at $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is currently owned by company insiders.

Remove Ads

Institutional Trading of Cardlytics

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Tallon Kerry Patrick acquired a new position in shares of Cardlytics in the 4th quarter worth approximately $37,000. Atom Investors LP bought a new position in Cardlytics during the third quarter worth $33,000. ProShare Advisors LLC acquired a new position in Cardlytics in the fourth quarter valued at $43,000. Intech Investment Management LLC bought a new stake in Cardlytics during the third quarter valued at $47,000. Finally, Virtu Financial LLC acquired a new stake in Cardlytics during the 4th quarter worth about $62,000. Institutional investors and hedge funds own 68.10% of the company's stock.

Cardlytics Price Performance

CDLX traded down $0.26 during trading on Friday, hitting $2.16. 768,854 shares of the stock traded hands, compared to its average volume of 1,127,869. The business has a 50 day moving average price of $2.89 and a 200 day moving average price of $3.43. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics has a twelve month low of $1.77 and a twelve month high of $20.52. The company has a market cap of $112.50 million, a price-to-earnings ratio of -0.35 and a beta of 1.62.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.